
ROCKVILLE, Md. -- The FDA has ordered all drugs approved for attention deficit hyperactivity disorder to carry guides to inform patients about the potential for cardiovascular risks and adverse psychiatric symptoms.

ROCKVILLE, Md. -- The FDA has ordered all drugs approved for attention deficit hyperactivity disorder to carry guides to inform patients about the potential for cardiovascular risks and adverse psychiatric symptoms.

NEW ORLEANS -- Although pharmacological treatments are the mainstay of therapy for attention-deficit hyperactivity disorder (ADHD) in adults, psychosocial treatments can be a useful adjunct and improve patients' quality of life.

NEW ORLEANS -- Attention-deficit hyperactivity disorder (ADHD), often thought of as a condition of childhood, may persist into adolescence and adulthood, causing serious life problems, investigators said here.

SAN DIEGO -- An investigational d-amphetamine prodrug appears to be effective in treating pediatric attention deficit hyperactivity disorder, with the goal of less abuse potential than amphetamines, researchers said.

SAN DIEGO, Calif. -- Strattera (atomoxetine) given to children with attention deficit hyperactivity disorder does not appear to stunt growth over the long term, according to a lengthy study.

ATLANTA ? Stimulants used to treat attention deficit-hyperactivity disorder (ADHD) that are accidentally overdosed or trigger adverse reactions lead to more than 3,000 emergency room visits a year, estimate CDC researchers.